{
  "id": "54f89e1a06d9727f76000001",
  "type": "factoid",
  "question": "Which kinase is inhibited by the small molecule KN-93?",
  "ideal_answer": "The calcium/calmodulin-dependent protein kinase-II (CaMK-II) is inhibited by the small molecule KN-93. KN-93 is a membrane-permeant calcium/calmodulin- dependent kinase II (CaMK-II)-selective inhibitor",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17457979",
    "http://www.ncbi.nlm.nih.gov/pubmed/16896952",
    "http://www.ncbi.nlm.nih.gov/pubmed/14749212",
    "http://www.ncbi.nlm.nih.gov/pubmed/9864285",
    "http://www.ncbi.nlm.nih.gov/pubmed/15569687",
    "http://www.ncbi.nlm.nih.gov/pubmed/22290426",
    "http://www.ncbi.nlm.nih.gov/pubmed/11827960",
    "http://www.ncbi.nlm.nih.gov/pubmed/11164895",
    "http://www.ncbi.nlm.nih.gov/pubmed/11248432",
    "http://www.ncbi.nlm.nih.gov/pubmed/7690557",
    "http://www.ncbi.nlm.nih.gov/pubmed/8939965",
    "http://www.ncbi.nlm.nih.gov/pubmed/21187407",
    "http://www.ncbi.nlm.nih.gov/pubmed/9596994",
    "http://www.ncbi.nlm.nih.gov/pubmed/15175389",
    "http://www.ncbi.nlm.nih.gov/pubmed/10712242",
    "http://www.ncbi.nlm.nih.gov/pubmed/1662507"
  ],
  "snippets": [
    {
      "text": "KN-93, a membrane-permeant calcium/calmodulin- dependent kinase-selective inhibitor, induces apoptosis in some lines of human tumor cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22290426",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Knockdown of \u03b2CaMKII by lentiviral-mediated expression of shRNA prevented the synaptic inactivity-induced increase in GluA1, as did treatment with the CaM kinase inhibitor KN-93, but not the inactive analog KN-92.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21187407",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To investigate the effects of KN-93, a CaMKII selective inhibitor on cell proliferation and the expression of p53 or p21 protein in human hepatic stellate cells. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17457979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Injection of the CaM kinase inhibitor KN-93 into pupae resulted in a reduced number of antennal lobe glial cells migrating into the neuropil to form borders around glomeruli.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16896952",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In contrast, addition of the intracellular Ca2+ chelator BAPTA-AM or the Ca2+/calmodulin-dependent (CaM) kinase inhibitor KN93 blocked reporter gene activation in response to IH.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15569687",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These increases in CPEB phosphorylation were attenuated by a specific peptide inhibitor of CaMKII and by the general CaM-kinase inhibitor KN-93.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15175389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Alternatively, treatment with KN-93, a selective inhibitor of CaMKII activation, or adenoviral overexpression of kinase-negative CaMKII-delta(2), inhibited ATP-dependent activation of ERK1/2 but had no effect on PDBu- or PDGF-stimulated ERK1/2.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14749212",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ca(2+)/CaM-dependent protein kinase inhibitor KN-93 also blocked zygote elongation, while its ineffective analog KN-92 did not have such effect.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11827960",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CaM kinase inhibitor KN93 on its own exhibits little toxicity up to 10 mM, as measured by release of lactate dehydrogenase (LDH) into the culture medium.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11248432",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To further elucidate the mechanism by which calcium-induced ERK activation occurs, we used the CaM-kinase inhibitor KN-93 and an inactive analog of KN-93 (KN-92).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11164895",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hearts were pretreated with the CaM kinase inhibitor KN-93 or the inactive analog KN-92 (0.5 microM) for 10 min before clofilium exposure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9864285",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The calmodulin-dependent protein kinase-II (CaMK-II) inhibitor KN-93 has been shown to reversibly arrest mouse and human cells in the G1 phase of the cell cycle",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9596994",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8939965",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A novel Ca2+/calmodulin-dependent protein kinase II (CaM Kinase II) inhibitor, KN-93 potently inhibits gastric acid secretion from parietal cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7690557",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10712242",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In vitro, KN-93 potently inhibited rabbit myocardial CaM kinase activity (calculated Ki",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9864285",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "KN-93 also inhibited the autophosphorylation of both the alpha- and beta-subunits of CaMKII.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1662507",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10712242",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In vitro, KN-93 potently inhibited rabbit myocardial CaM kinase activity (calculated Ki </= 2.58 microM), but the inactive analog KN-92 did not (Ki > 100 microM)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9864285",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.biosemantics.org/jochem#4263678",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007266"
  ],
  "exact_answer": "The calcium/calmodulin-dependent protein kinase-II, CaM kinase II, CAMK2"
}